Proven to reduce procedure time by 17%1 by experiencing the outstanding performance of the Azurion 7 M12. This industry-leading image-guided solution supports better patient care and operational efficiency with seamless control from a single tableside touch screen for fast, informed decisions in the sterile field.
Find the right path and improve PCI outcomes. This Philips exclusive solution offers motion-compensated, real-time navigational guidance of coronary arteries and reduces contrast agent use by 28.8%2.
Philips IntraSight offers you a comprehensive suite of clinically proven3-7 imaging, physiology and co-registration8 tools on a modern, secure platform that will help you simplify complex interventions, speed routine procedures and improve lab efficiencies.
Providing superb image quality at ultra-low dose settings.
Backed by clinically validated patient data in the largest physiology studies ever, learn how iFR reduces costs, procedural time and patient discomfort.
[1] Philips whitepaper 12nc 4522 991 30501;Reduction of procedure time by 17% with Philips Azurion in independently verified study; www.philips.com/healthcare/resources/landing/azurion/lab-performance-study-results. Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.
[2] Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4 Contrast trial www.documents.philips.com/assets/20240219/0e2a77c4a6904c6eaae3b11b00df6861.pdf
[3] Davies JE, et al., DEFINE-FLAIR: A Multi- Centre, Prospective, International, Randomized, Blinded Comparison of Clinical Outcomes and Cost Efficiencies of iFR and FFR Decision-Making for Physiological Guided Coronary Revascularization. New England Journal of Medicine, epub March 18, 2017.
[4] Gotberg M, et al., Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve Guided Intervention (IFR-SWEDEHEART): A Multicenter, Prospective, Registry-Based Randomized Clinical Trial. New England Journal of Medicine, epub March 18, 2017.
[5] Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision-making.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.
[6] A. Maehara, M. Matsumura, Z.A. Ali, G.S. Mintz, G.W. Stone. IVUS-guided versus OCT-guided coronary stent implantation. J Am Coll Cardiol Img, 10 (2017), pp. 1487- 1503.
[7] Choi K, et al. Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing Complex Procedures. JACC: Cardiovascular Interventions. Mar 2019, 4281; DOI: 10.1016/j.jcin.2019.01.227.
[8] Co-registration tools available within IntraSight 7 configuration via SyncVision
Always read the label and follow the directions for use. Philips medical devices should only be used by physicians and teams trained in interventional techniques, including training in the use of this device. Products subject to country availability. Please contact your local sales representative. ©2024 Koniklijke Philips N.V. All rights reserved. Trademarks are the property of Koninklijke Philips N.V. or their respective owners. Philips reserves the right to change product specifications without prior notification.
You are about to visit a Philips global content page
Continue